Terumo (OTCMKTS:TRUMY) Shares Gap Down – Time to Sell?

Terumo Corp. (OTCMKTS:TRUMY) shares gapped down before the market opened on Wednesday . The stock had previously closed at $13.80, but opened at $13.39. Terumo shares last traded at $13.3770, with a volume of 24,874 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Terumo to a “hold” rating in a research note on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of “Hold”.

Terumo Stock Down 2.9%

The firm has a market capitalization of $19.77 billion, a PE ratio of 21.98 and a beta of 0.68. The company has a fifty day moving average price of $13.85 and a 200-day moving average price of $13.59. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a net margin of 12.09% and a return on equity of 9.17%. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. As a group, analysts expect that Terumo Corp. will post 0.7 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.